Let us know if you would like to be actively involved in ECTS activities and you may be called tobe part in one of our committees or action groups.Become an ECTS member here and complete an online form here
Education and Events:
ECTS 2021 Charity Event: May 19th at 18:00 more information and registrationhere
The ECTS training program for 2021 is intense in the sense that various activities are scheduled in three areas: a course dedicated to PhD students, a course to clinical scientists and monthly webinars.
The course for PhD students is a classic event that ECTS has been organizing for years, and with the change to virtual it has been called “Digital Masterclass PhD 2021”. It is an interactive course in which there are presentations by senior scientists, members of the ECTS Academy and GEMSTONE, and students also present their projects. There is mentoring, and cross-cutting themes will be addressed. This year the course will start with the basics of bone cells, basic and clinical aspects of topics such as hormones, genetics, osteoarthritis and research models and aspects of bioinformatics will be discussed. To learn more and register check here.
The Australian and New Zealand Bone and Mineral Society. By Rachel Davey, Councillor and Chair of ANZBMS Communications Committee
The Australian and New Zealand Bone and Mineral Society (ANZBMS, www.anzbms.org.au, @ANZBMSoc) was established in 1988 with Prof. T. J. Martin as Founding President.
The ANZBMS is the principal professional body for biomedical scientists and clinicians involved in research and in management of patients in the field of metabolic bone disease and mineral metabolism in Australia and New Zealand. ANZBMS is dedicated to promoting excellence in bone and mineral research, fostering the integration of clinical and basic science, and facilitating the translation of our science to health care and clinical practice.
Fracture risk in patients with rheumatoid arthritis treated with glucocorticoids and proton pump inhibitors. By Barbara Hauser
Rheumatoid Arthritis (RA) is a chronic inflammatory disease with an increased risk of osteoporosis which is partly due to the disease itself and partly due to medication, in particular glucocorticoids (GC). About one quarter of RA patients are prescribed oral glucocorticoids which increases the fracture risk substantially. Proton pump inhibitors (PPI) are frequently co-prescribed in order to prevent gastrointestinal side effects of GC or Non-steroidal anti-inflammatory medications. PPI use has been associated to a possible increased fracture risk, however the magnitude and underlying mechanism of PPIs on fracture risk are not well understood.
A retrospective cohort study by Abtahi et al included RA patients over 50 years of age who were included in the UK Clinical Practice database over a 20 years time frame. GC and PPI intake was stratified into current, recent or past use. Time-dependent Cox proportional-hazards models allowed to estimate the risk of an osteoporotic fracture in RA patients with concomitant current use of oral GCs and PPIs versus non-use.
Let us know if you would like to be actively involved in ECTS activities and you may be called tobe part in one of our committees or action groups.Become an ECTS member here and complete an online form here
Education and Events:
ECTS 2021 Charity Event: May 19th at 18:00 more information and registrationhere
ECTS is thankful to its Corporate Members and other companies that have supported ECTS activities through unrestricted educational grants. These sponsors have in no way contributed to or influenced the content.
STAY CONNECTED:
Editor in chief: Petar Milovanovic (Belgrade, Serbia)
Co-editors: Cristiana Cipriani (Rome, Italy), Antonia Sophocleous (Cyprus), Barbara Hauser (Edinburgh, UK), Antonio Maurizi (L'Aquila, Italy)
